|
Navigation
Search
|
A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating
Wednesday November 29, 2023. 06:16 PM , from Wired: Tech.
CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.
https://www.wired.com/story/a-cutting-edge-cancer-treatment-is-under-fda-investigation-for-cancer-ri
|
25 sources
Current Date
Dec, Sat 13 - 18:47 CET
|
Read more at Wired: Tech.